5 related news articles for Respiratory and Lung

  • Using our immune system to fight COVID-19

    There is something unusual about the initial—or innate—immune response to COVID-19 compared to usual influenza patterns. …  Read more

    Professor Paul Hertzog from the Regulation of Interferon and Innate Signalling Research Group at Hudson Institute

  • Melbourne Inflammation Symposium

    More than 120 medical research scientists in the field of inflammation converged at Hudson Institute of Medical Research today to share knowledge and find solutions for patients across a broad range of diseases.…  Read more

    Husdson Institute CiiiD team

  • High-dose steroids don’t prevent asthma flare-ups

    High doses of glucocorticoids are not effective in preventing life-threatening asthma flare-ups, according to a landmark study published in The New England Journal of Medicine (NEJM). Glucocorticoids are anti-inflammatory medications used in many everyday prescription asthma puffers, such as turbuhalers or accuhalers. Hudson Institute research group head, Professor Phil Bardin was invited by the NEJM…  Read more

    Prof Phil Bardin

  • $10 million in NHMRC funding for research including breast cancer, asthma and fetal hypoxia

    Hudson Institute researchers have been awarded more than $10 million in funding by the National Health and Medical Research Council (NHMRC).…  Read more

    Baby

  • WWI antiseptic could fight 21st century viral infections

    Melbourne researchers have shown that a century-old topical antiseptic used to treat wounds and ‘sleeping sickness’ in Australian soldiers in World War One could activate the immune system to protect against viral infection, and may prove key in the fight against antibiotic resistance.…  Read more

    Michael Gantier and leam in the lab